AIDS Weekly
Susan Hasty, Publisher
Table of Contents . . . September 6th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
Conference Coverage (IHV) - Gallo: Don't Quit Quest for Sterilizing AIDS Vaccine
Breastfeeding - Dilemma Continues For Resource-Poor Women
Conference Coverage (IHV) - Novel Chemokine Seen As Lead Molecule for AIDS Therapy
Neurodegeneration - Inflammatory Cytokine Disables Neuronal Survival Factor
Coinfection (TB/HIV) - HIV Replication in M. tb Infected Patients Studied
Gene Transfer - HIV DNA Is Transferred by an HIV Receptor-Independent Mechanism
Blood Safety (HCV) - QIAamp Kits Approved in Germany for Screening Blood Supply
Drug Development - Coming Closer To Stopping HIV in Its Tracks
Drug Resistance - Researchers Discover Genetic Reason Why Some Patients Resist Therapy
Epidemiology - Minister Predicts Six Million S. Africans with HIV
Ethics - Fraud Information Network Offers Free Training to Texas AIDS Organizations
Funding - HIV-VAC Announces $5 Million Funding Commitment to Develop AIDS Vaccine
HIV Vaccines - World Bank Works To Develop an Affordable, Effective HIV Vaccine
Industry News (AIDS Therapies) - AIDS Drug Chosen for Further Testing
Industry News (Cachexia) - Patent Allowance Announced for Oxandrin To Treat HIV Wasting
Needle Exchange Programs (Government) - APLA Applauds State Senate for Passing Legislation
Protease Inhibitors (Clinical Trials) - Center Tests New Generation of HIV Drugs
Syphilis (Epidemiology) - Syphilis Outbreak Traced to Internet Chat Room
Transmission (Vertical) - HIV Breastfeeding Risk Highest in Early Months After Birth
Drug Development (Antiviral) - "Inhibition of HIV-1 Replication by New 6-Amino-Quinolone Compounds."
Breast Cancer (HIV+) - "Breast Cancer and HIV: What To Expect in the New Millenium."
Drug Development (Antiviral) - "PAF-Antagonists with Anti-HIV-1 Activity."
Drug Development (Antiviral) - "Quantitative Normalization of CD4 Cells in Blood and Lymph Node of HIV Infected Adults at Early Stage of Chronic Infection and No Previous Antiretroviral Therapy Treated with Ziagen Plus Amprenavir."
Pediatrics (HAART) - "Downregulation of CD95-Sensitivity in CD4+ T Cells from HIV Infected Children Is Sufficient for Immune Reconstitution During HAART."
AIDS Therapies - "Delays in Protease Inhibitor Use in Clinical Practice."
Immunology - "The Human Uniqueness of HIV: Innate Immunity and the Viral Tat Protein."
Pediatrics - "General Practice and the Care of Children With HIV Infection: 6 Month Prospective Interview Study."
Vaginal Microbicides - "Acceptability of a Vaginal Microbicide Among Female Sex Workers."
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
